Aixcrypto Holdings Inc (AIXC) Stock Price, Quote & News

Company Profile

AIxCrypto Holdings, Inc. focuses on building an ecosystem that integrates Artificial Intelligence and blockchain while bridging Web2 and Web3. Its principal products include the BesTrade DeAI Agent and the AIxC ecosystem products. The company was formerly known as Qualigen Therapeutics, Inc. and changed its name to AIxCrypto Holdings, Inc. in November 2025. AIxCrypto Holdings, Inc. was founded in 1996 and is based in Carlsbad, California.

Industry: Software - Infrastructure

Sector: Technology

Phone: 760 452 8111

Website: www.aixcrypto.ai

Address:

5857 Owens Avenue, Suite 300, Carlsbad, United States

BounceChad Feb. 17 at 9:07 AM

$AIXC Obscure micro-cap; minimal coverage

0 · Reply

theflynews Feb. 13 at 3:12 PM

Crypto Currents: Coinbase, Robinhood post Q4 results - $AIXC - https://legacy.thefly.com/permalinks/entry.php/id4293004

0 · Reply

peepthestamp Feb. 13 at 1:12 PM

$AIXC -Buy Lows

0 · Reply

ankkaaaaaa Feb. 13 at 9:38 AM

$AIXC what happened?

0 · Reply

mikesterz7 Feb. 12 at 12:44 PM

$AIXC The company announced a strategic partnership with BitMart to introduce a virtual prepaid card.

0 · Reply

StocktwitsNews Feb. 12 at 10:52 AM

Why AIxCrypto Stock Is Rising Pre-Market Today? $AIXC $VXF https://stocktwits.com/news/equity/markets/why-aix-crypto-stock-is-rising-pre-market-today/cZRTKKOR4r3

0 · Reply

ankkaaaaaa Feb. 10 at 3:10 PM

$AIXC a scam that might pump🤷‍♂️ bearish long term but bullish short term

0 · Reply

FadeCruze Feb. 9 at 11:22 AM

$AIXC is an AI-powered customer experience platform; the market is fragmented, and consolidation is likely; the company must grow rapidly to become an acquirer rather than being acquired at a low multiple.

0 · Reply

StocktwitsNews Feb. 5 at 12:21 PM

What Triggered AIXC Stock’s 8% Jump In Pre-Market Today? $AIXC $FFAI https://stocktwits.com/news/equity/markets/why-axic-stock-surging-today-faraday-future-robotics/cZbZEHiR4Vf

0 · Reply

BullishAaFf Feb. 4 at 10:34 PM

$FFAI $AIXC 💎💎💎💎💎

0 · Reply

AIxCrypto Co-CEO Jerry Wang Shares Weekly Investor Update: BitMart Partnership, Hub Milestone, and Institutional & Industry Engagement

Feb 12, 2026, 5:24 AM EST - 5 days ago

AIxC and BitMart Advance Co-Branded Virtual Card Partnership

Feb 2, 2026, 11:21 AM EST - 14 days ago

AIxCrypto Co-CEO Jerry Wang Shares Weekly Investor Update: $10 million FFAI Strategic Investment, 1M+ Wallets, and Sei Collaboration

Feb 2, 2026, 11:21 AM EST - 14 days ago

AIxC and Sei Development Foundation Announce Strategic Collaboration

Jan 28, 2026, 3:01 PM EST - 19 days ago

AIxCrypto Inc. Surpasses 1.1 Million Registered Wallets as AIxC Hub Launches "Tenki" Interactive Game

Jan 23, 2026, 12:24 AM EST - 25 days ago

AIXC Continues Strategic Corporate Expansion to Support Hyper-Growth of AIxC Hub Ecosystem

Jan 15, 2026, 8:54 PM EST - 4 weeks ago

AIxC Announces AIxC Hub Exceeds 500,000 Registered Wallets in First Week Following Launch

Jan 6, 2026, 1:39 PM EST - 5 weeks ago

AIxC to Advance Tokenization Strategy with Proposed Strategic Investment in Faraday Future

FFAI

Dec 23, 2025, 9:00 AM EST - 7 weeks ago

AIxCrypto Establishes UAE Subsidiary and Obtains Web3 Operations License Approval to Support Global AI and Web3 Expansion

Dec 17, 2025, 1:01 AM EST - 2 months ago

AIxC Appoints Andrew Grossman As Head of Legal Where He Will Direct the Company's Legal, Compliance, and Governance Strategy

FFAI

Dec 14, 2025, 11:44 PM EST - 2 months ago

YT Jia, Chief Advisor to AIxC Shares Weekly AIxC Investor Update: AIxC Appointed Andrew Grossman as Head of Legal Where he will Take Full Responsibility for the Company's Legal, Compliance, and Governance Framework

FFAI

Nov 20, 2025, 12:36 PM EST - 3 months ago

AIxCrypto Rebrands and Begins Trading Under New Ticker AIXC, Advancing Its "Three Driving Forces" Strategy to Become the No.1 Gateway to AI Web3 and a Bridge Between Web2 and Web3

Nov 16, 2025, 4:10 PM EST - 3 months ago

Qualigen Therapeutics Stockholders Approve All Proposals with Majority Vote; Company to Rebrand as AIxCrypto Holdings, Inc. (Nasdaq: AIXC) Following November 20 Nasdaq Ceremony and Announces Transition into AI × Web3 Strategy

Oct 27, 2025, 11:57 PM EDT - 4 months ago

Qualigen Therapeutics to Rebrand as AIxCrypto After Stockholder Meeting on November 12, with Three Core Goals for 2025

Oct 24, 2025, 3:12 AM EDT - 4 months ago

Qualigen Therapeutics (QLGN) Stock Soars 62% After-Hours On Partnership With BitGo To Build Multi-Asset Crypto Treasury

BTGO

Oct 23, 2025, 4:05 PM EDT - 4 months ago

Qualigen Therapeutics Partners with BitGo to Execute First Multi-Asset C10 Treasury Allocation

Oct 12, 2025, 9:00 PM EDT - 4 months ago

Qualigen Therapeutics Announces the Official Launch of C10 Cryptocurrency Asset Treasury (DAT) Purchases: Why Is This Pullback the Golden Moment CXC10 Has Been Waiting For?

Oct 6, 2025, 7:00 PM EDT - 4 months ago

Qualigen Therapeutics (NASDAQ: QLGN) Announces Executives, Board of Directors Appointments and Auditor Transition

Sep 30, 2025, 4:00 PM EDT - 4 months ago

Univest Securities, LLC Announces Closing of $41 Million Strategic Investment in Client Qualigen Therapeutics (NASDAQ: QLGN) from Client Faraday Future (NASDAQ: FFAI)

FFAI

Sep 30, 2025, 7:08 AM EDT - 5 months ago

Qualigen Therapeutics Announces Successful Closing of $41 Million PIPE Financing Led by Faraday Future, Accelerating New Business Transformation into Crypto

Sep 19, 2025, 6:01 PM EDT - 5 months ago

Faraday Future Announces Strategic $41 Million Investment in Qualigen Therapeutics, Inc. (NASDAQ: QLGN) f for Crypto Business Through PIPE Transaction

Jul 28, 2025, 12:41 PM EDT - 7 months ago

Qualigen Therapeutics Announces $4.5 Million Private Placement of Series A-3 Convertible Preferred Stock

May 19, 2025, 5:25 PM EDT - 9 months ago

Qualigen Therapeutics, Inc. receives expected notification of deficiency from Nasdaq related to delayed filing of quarterly report on Form 10-Q

May 1, 2025, 4:20 PM EDT - 10 months ago

Qualigen Therapeutics, Inc. Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Annual Report on Form 10-K

Nov 25, 2024, 5:00 PM EST - 1 year ago

Univest Securities, LLC Announces Successful Closing of $5.1 Million Private Placement for Qualigen Therapeutics, Inc. (NASDAQ: QLGN)

Nov 1, 2024, 9:00 AM EDT - 1 year ago

Shares Expected to Begin Trading on Split-Adjusted Basis on November 5, 2024

Sep 26, 2024, 5:10 PM EDT - 1 year ago

Qualigen Therapeutics, Inc. Announces management changes.

Sep 20, 2024, 9:00 AM EDT - 1 year ago

Qualigen Therapeutics, Inc. Received Extension from Nasdaq Hearings Panel

Sep 6, 2024, 5:00 PM EDT - 1 year ago

Univest Securities, LLC Announces Closing of $3.46 Million Registered Direct Offering for its Client Qualigen Therapeutics, Inc. (NASDAQ: QLGN)

Sep 6, 2024, 4:30 PM EDT - 1 year ago

Qualigen Therapeutics, Inc. Announces Closing of $3.47 Million Public Offering

Sep 5, 2024, 9:00 AM EDT - 1 year ago

Qualigen Therapeutics, Inc. Announces Pricing of $3.46 Million Public Offering

May 30, 2024, 4:00 PM EDT - 1 year ago

Qualigen Therapeutics, Inc. Received Nasdaq Notice of a Delisting Determination

Apr 10, 2024, 8:00 AM EDT - 2 years ago

Qualigen Therapeutics' Novel Direct Pan-RAS Inhibitors Presented at American Association of Cancer Research (AACR) 2024 Annual Meeting

Apr 9, 2024, 8:00 AM EDT - 2 years ago

Qualigen Therapeutics Announces Poster Featuring Positive Early Clinical Experience with QN-302, a Novel First-in-Class G-Quadruplex Experimental Anti-Cancer Drug, at the American Association of Cancer Research (AACR) 2024 Annual Meeting

Nov 14, 2023, 4:30 PM EST - 2 years ago

Qualigen Therapeutics Provides Corporate Update for Third Quarter and To Date 2023

Nov 7, 2023, 8:30 AM EST - 2 years ago

Qualigen Therapeutics Announces First Patient Dosed in the Phase 1a Clinical Trial of QN-302 for Treatment of Advanced or Metastatic Solid Tumors

Oct 23, 2023, 8:30 AM EDT - 2 years ago

Poster Highlighting Qualigen Therapeutics' Pan-RAS Inhibitor Platform Presented at AACR Special Conference: Advances in Breast Cancer

Sep 27, 2023, 8:30 AM EDT - 2 years ago

Qualigen Therapeutics Presents Scientific Data on QN-302 at AACR Special Conference: Pancreatic Cancer 2023

Aug 17, 2023, 8:30 AM EDT - 2 years ago

Qualigen Therapeutics Partners with TD2 for Phase 1 Clinical Development of QN-302 for the Treatment of Advanced or Metastatic Solid Tumors

Aug 15, 2023, 8:30 AM EDT - 2 years ago

Qualigen Therapeutics, Inc. Reports Financial Results and Corporate Update for Quarter Ending June 30, 2023

Aug 1, 2023, 8:30 AM EDT - 2 years ago

Qualigen Therapeutics Announces US FDA IND Clearance to Initiate Phase 1 Clinical Trial of QN-302 for Treatment of Advanced or Metastatic Solid Tumors

Jul 24, 2023, 8:15 AM EDT - 2 years ago

Qualigen Therapeutics Divests FastPack® Diagnostics Business

Jun 5, 2023, 8:15 AM EDT - 2 years ago

Poster Highlighting Qualigen Therapeutics' Pan-RAS Inhibitor Platform Presented at American Society of Clinical Oncology (ASCO) 2023 Annual Meeting

May 2, 2023, 4:30 PM EDT - 3 years ago

Qualigen Therapeutics, Inc. Reports Fourth Quarter and Year-End 2022 Financial Results and Provides Corporate Update

May 2, 2023, 8:15 AM EDT - 3 years ago

Qualigen Therapeutics' Pan-RAS Inhibitor Program Highlighted in Two Abstracts at American Society of Clinical Oncology (ASCO) 2023 Annual Meeting

Apr 21, 2023, 5:46 PM EDT - 3 years ago

Qualigen Therapeutics, Inc. Receives Nasdaq Notice Regarding Delayed Form 10-K Filing

Apr 18, 2023, 8:45 AM EDT - 3 years ago

Qualigen Therapeutics Announces Four Posters on QN-302 Presented at the American Association of Cancer Research (AACR) 2023 Annual Meeting in Orlando, FL

Apr 18, 2023, 7:30 AM EDT - 3 years ago

Qualigen Therapeutics Presents Data On QN-247 in Triple Negative Breast Cancer at the American Association for Cancer Research (AACR) Annual Meeting in Orlando, FL

Mar 21, 2023, 8:35 AM EDT - 3 years ago

Composition of Matter Patent for QN-302 Granted by United States Patent and Trademark Office

Mar 15, 2023, 9:05 AM EDT - 3 years ago

Qualigen Therapeutics to Present Five Posters at the American Association for Cancer Research Annual Meeting 2023

BounceChad Feb. 17 at 9:07 AM

$AIXC Obscure micro-cap; minimal coverage

0 · Reply

theflynews Feb. 13 at 3:12 PM

Crypto Currents: Coinbase, Robinhood post Q4 results - $AIXC - https://legacy.thefly.com/permalinks/entry.php/id4293004

0 · Reply

peepthestamp Feb. 13 at 1:12 PM

$AIXC -Buy Lows

0 · Reply

ankkaaaaaa Feb. 13 at 9:38 AM

$AIXC what happened?

0 · Reply

mikesterz7 Feb. 12 at 12:44 PM

$AIXC The company announced a strategic partnership with BitMart to introduce a virtual prepaid card.

0 · Reply

StocktwitsNews Feb. 12 at 10:52 AM

Why AIxCrypto Stock Is Rising Pre-Market Today? $AIXC $VXF https://stocktwits.com/news/equity/markets/why-aix-crypto-stock-is-rising-pre-market-today/cZRTKKOR4r3

0 · Reply

ankkaaaaaa Feb. 10 at 3:10 PM

$AIXC a scam that might pump🤷‍♂️ bearish long term but bullish short term

0 · Reply

FadeCruze Feb. 9 at 11:22 AM

0 · Reply

StocktwitsNews Feb. 5 at 12:21 PM

What Triggered AIXC Stock’s 8% Jump In Pre-Market Today? $AIXC $FFAI https://stocktwits.com/news/equity/markets/why-axic-stock-surging-today-faraday-future-robotics/cZbZEHiR4Vf

0 · Reply

BullishAaFf Feb. 4 at 10:34 PM

$FFAI $AIXC 💎💎💎💎💎

0 · Reply

Rasa1427 Feb. 4 at 3:23 PM

$AIXC will see 1.4

1 · Reply

waywardmx5 Feb. 3 at 2:33 AM

$AIXC YT Jia is now taking "consulting" fee's out of the company at $100,000/month and millions in bonuses thru his related company, FF Global Partners. Using the company as his own piggy bank.

1 · Reply

StocktwitsNews Feb. 2 at 6:14 PM

AIxCrypto Shares Are Rising Today – Here’s Why $AIXC $VXF https://stocktwits.com/news/equity/markets/aixcrypto-shares-are-rising-today-know-why/cZbguuqR4kY

0 · Reply

BullishAaFf Feb. 2 at 4:25 AM

$FFAI $AIXC https://www.stocktitan.net/news/FFAI/faraday-future-founder-and-co-ceo-yt-jia-shares-weekly-investor-a35u74iewmax.html

0 · Reply

BullishAaFf Feb. 2 at 4:07 AM

$FFAI $AIXC

0 · Reply

Ric_1M Jan. 24 at 11:20 AM

$BNAI $CXAI $GXAI $ARAI $AIXC “If you want to do this, if you want to play big, if you want to really impact lives, you’ve got to face yourself. You’ve got to be courageous and willing to go all in and address everything about you that is uncomfortable.” Harry Lopez

0 · Reply

ankkaaaaaa Jan. 22 at 6:19 AM

$AIXC we are cooked🥲

0 · Reply

Marcanwin2025 Jan. 21 at 3:59 AM

$AIXC CO CEO Jerry Wang first weekly update AIXC https://x.com/i/status/2013314377084965106

0 · Reply

Marcanwin2025 Jan. 21 at 3:56 AM

$AIXC

0 · Reply

RealFaradayFuture Jan. 20 at 1:32 AM

YT Jia's Dual Public Company Structure Weekly Update 038 $FFAI $AIXC https://youtu.be/ir0PxzpRDfE EAI Flywheel ① FF/FX is redefining the dealer model—from one-time vehicle sales to a sustainable ecosystem driven by sales + user operations, while enabling dealers to become OEM stockholders and share long-term value. ② On Feb 4 at NADA Show (Booth 6030N), FF will launch its Embodied AI Robotics and FF/FX Par program, becoming the first U.S. next-gen EV company at NADA and the first automaker to introduce EAI robotics to dealers. ③ FF will also showcase FF 91, FX Super One, and EAI robotics at UMEX 2026 (Jan 20–22, Abu Dhabi). Crypto Flywheel AIxC Hub launched globally on Jan 7, attracting hundreds of thousands of wallets and quickly becoming a leading new platform in Web3.

0 · Reply

taurean_bull Jan. 16 at 10:15 PM

$AIXC so does this mean we arent getting eua

0 · Reply

Trader1141 Jan. 16 at 5:40 PM

$VERO nice!! $AIXC has good news today… just needs a little bit of volume to take off

0 · Reply

Market Cap	6.71M
Revenue (ttm)	0.00
Net Income (ttm)	-6.26M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.01

Volume	52,300
Avg Vol	87,066
Day's Range	N/A - N/A
Shares Out	5.16M
Stochastic %K	20%
Beta	0.34
Analysts	Strong Buy
Price Target	N/A